- Pfizer scraps daily weight loss pill after liver injury in one patient CNBC
- Pfizer Abandons Obesity Pill After Liver Injury in Major Setback Bloomberg.com
- Pfizer Stock Falls. It’s Halted Development of New Weight-Loss Drug. Barron’s
- Pfizer to discontinue its GLP-1 pill for obesity due to liver toxicity statnews.com
- Pfizer Halts Development of Weight-Loss Pill WSJ
Credit: Source link